Literature DB >> 19287351

Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus.

Neal J Thomas1, Susan DiAngelo, Joseph C Hess, Ruzong Fan, Margaret W Ball, Joseph M Geskey, Douglas F Willson, Joanna Floros.   

Abstract

Severity of lung injury with respiratory syncytial virus (RSV) infection is variable and may be related to genetic variations. This preliminary report describes a prospective, family-based association study of children hospitalized secondary to RSV, aimed to determine whether intragenic and other haplotypes of surfactant proteins (SP)-A and SP-D are transmitted disproportionately from parents to offspring with RSV disease. Genomic DNA was genotyped for several SP-A and SP-D single nucleotide polymorphisms (SNPs). Transmission disequilibrium test analysis was used to determine transmission of variants and haplotypes from parents to affected offspring. Three hundred seventy-five individuals were studied, including 148 children with active RSV disease and one or both parents. The SP-A2 intragenic haplotype 1A was found to be protective (p = 0.013). The SP-D SNP DA160_A may possibly be an "at-risk" marker (p = 0.0058). Additional two- and three-marker haplotypes were associated with severe RSV disease, with two being protective (DA11_T/DA160_G and DA160_G/SP-A2 1A/SP-A1 6A). We conclude that there may be associations between SP-A and SP-D and RSV disease. Further study is required to determine whether these variants can be used to target a high-risk patient population in clinical trials aimed at reducing either the symptoms of acute infection or long-term pulmonary sequelae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287351      PMCID: PMC2710771          DOI: 10.1203/PDR.0b013e3181a1d768

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  40 in total

1.  Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.

Authors:  Anatoly N Mikerov; Guirong Wang; Todd M Umstead; Mario Zacharatos; Neal J Thomas; David S Phelps; Joanna Floros
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.

Authors:  Johan Löfgren; Mika Rämet; Marjo Renko; Riitta Marttila; Mikko Hallman
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

Authors:  N Sigurs; R Bjarnason; F Sigurbergsson; B Kjellman
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

5.  Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada.

Authors:  S R Arnold; E E Wang; B J Law; F D Boucher; D Stephens; J L Robinson; S Dobson; J M Langley; J McDonald; N E MacDonald; I Mitchell
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

6.  Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

Authors:  A M LeVine; J Gwozdz; J Stark; M Bruno; J Whitsett; T Korfhagen
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

7.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

8.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

9.  TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease.

Authors:  Beena Puthothu; Johannes Forster; Andrea Heinzmann; Marcus Krueger
Journal:  Dis Markers       Date:  2006       Impact factor: 3.434

10.  Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma.

Authors:  Beena Puthothu; Johannes Forster; Jessica Heinze; Andrea Heinzmann; Marcus Krueger
Journal:  BMC Pulm Med       Date:  2007-05-11       Impact factor: 3.317

View more
  20 in total

1.  Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.

Authors:  Marianne Samir M Issac; Wafaa Ashur; Heba Mousa
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

2.  Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation.

Authors:  Sambuddho Mukherjee; Charles Giamberardino; Joseph Thomas; Kathy Evans; Hisatsugu Goto; Julie G Ledford; Bethany Hsia; Amy M Pastva; Jo Rae Wright
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

Review 3.  Pathogenesis of pneumonia and acute lung injury.

Authors:  Matthew E Long; Rama K Mallampalli; Jeffrey C Horowitz
Journal:  Clin Sci (Lond)       Date:  2022-05-27       Impact factor: 6.876

Review 4.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

Review 5.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 6.  Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

7.  Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study.

Authors:  M Isabel García-Laorden; Felipe Rodríguez de Castro; Jordi Solé-Violán; Olga Rajas; José Blanquer; Luis Borderías; Javier Aspa; M Luisa Briones; Pedro Saavedra; J Alberto Marcos-Ramos; Nereida González-Quevedo; Ithaisa Sologuren; Estefanía Herrera-Ramos; José M Ferrer; Jordi Rello; Carlos Rodríguez-Gallego
Journal:  Crit Care       Date:  2011-02-10       Impact factor: 9.097

8.  Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs.

Authors:  Julie G Ledford; Sambuddho Mukherjee; Michele M Kislan; Julia L Nugent; John W Hollingsworth; Jo Rae Wright
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV.

Authors:  Alastair Watson; Nina Kronqvist; C Mirella Spalluto; Mark Griffiths; Karl J Staples; Tom Wilkinson; Uffe Holmskov; Grith L Sorensen; Anna Rising; Jan Johansson; Jens Madsen; Howard Clark
Journal:  Immunobiology       Date:  2016-10-18       Impact factor: 3.144

10.  Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus.

Authors:  Stephanie Glineur; Dao Bui Tran Anh; Michaël Sarlet; Charles Michaux; Daniel Desmecht
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.